Breaking News

TriLink Opens New cGMP mRNA Manufacturing Facility in San Diego

Will support late-phase drug developers from Phase 2 to commercialization via TriLink’s mRNA manufacturing capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

TriLink BioTechnologies (TriLink), a Maravai LifeSciences company and global provider of life science reagents and services, has opened its new cGMP mRNA manufacturing facility in San Diego.   The 32,000-square-foot facility was specifically designed for mRNA manufacturing to support late-phase drug developers from Phase 2 to commercialization via TriLink’s mRNA manufacturing capabilities. The opening is expected to help advance the field of mRNA-based medicine as developers flock to leverage ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters